Viewing Study NCT03223103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2026-02-09 @ 2:49 PM
Study NCT ID: NCT03223103
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-10
First Post: 2017-07-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
Sponsor: Adilia Hormigo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Brain cancer View
None Glioblastoma View
None Personalized vaccine View
None Polyinosinic-polycytidylic acid (Poly-ICLC) View
None Immunotherapy View
None Cancer View
None NovoTTF-200A View
None Optune View
None GBM View
None immunogenicity View